Rockwell Medical, Inc. (RMTI) P/E Ratio History
Historical price-to-earnings valuation from 2003 to 2005
Loading P/E history...
RMTI Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Rockwell Medical, Inc. (RMTI) trades at a price-to-earnings ratio of -5.2x, with a stock price of $0.78 and trailing twelve-month earnings per share of $-40.81.
The current P/E is 101% below its 5-year average of 676.1x. Over the past five years, RMTI's P/E has ranged from a low of 67.2x to a high of 4389.0x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, RMTI trades at a 123% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, RMTI trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our RMTI DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
RMTI P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $8B | 25.5 | 1.11Best | -25% | |
| $13B | 20.6Lowest | 2.49 | -11% | |
| $6B | 64.8 | - | -86% | |
| $56B | 26.3 | 1.59 | -1%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
RMTI Historical P/E Data (2003–2005)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2005 Q4 | Sat Dec 31 2005 00:00:00 GM | $49.17 | $0.05 | 983.4x | +45% |
| FY2005 Q3 | Fri Sep 30 2005 00:00:00 GM | $41.69 | $0.46 | 90.8x | -87% |
| FY2005 Q2 | $34.65 | $0.35 | 99.2x | -85% | |
| FY2005 Q1 | $36.08 | $0.35 | 103.3x | -85% | |
| FY2004 Q4 | Fri Dec 31 2004 00:00:00 GM | $34.65 | $0.35 | 99.2x | -85% |
| FY2004 Q3 | $32.78 | $0.46 | 71.3x | -89% | |
| FY2004 Q2 | Wed Jun 30 2004 00:00:00 GM | $30.91 | $0.46 | 67.2x | -90% |
| FY2004 Q1 | Wed Mar 31 2004 00:00:00 GM | $41.69 | $0.23 | 181.3x | -73% |
| FY2003 Q4 | Wed Dec 31 2003 00:00:00 GM | $43.89 | $0.01 | 4389.0x | +549% |
Average P/E for displayed period: 676.1x
See RMTI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RMTI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RMTI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRMTI — Frequently Asked Questions
Quick answers to the most common questions about buying RMTI stock.
Is RMTI stock overvalued or undervalued?
RMTI trades at -5.2x P/E, below its 5-year average of 676.1x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does RMTI's valuation compare to peers?
Rockwell Medical, Inc. P/E of -5.2x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is RMTI's PEG ratio?
RMTI PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2003-2005.